| Literature DB >> 27272557 |
Yuelin Song1, Qingqing Song1,2, Jun Li1, Shepo Shi1, Liping Guo3, Yunfang Zhao1, Yong Jiang4, Pengfei Tu1.
Abstract
Practicing "green analytical chemistry" is of great importance when profiling the chemical composition of complex matrices. Herein, a novel hybrid analytical platform was developed for direct chemical analysis of complex matrices by online hyphenating pressurized warm water extraction followed by turbulent flow chromatography coupled with high performance liquid chromatography-tandem mass spectrometry (PWWE-TFC-LC-MS/MS). Two parallel hollow guard columns acted as extraction vessels connected to a long narrow polyether ether ketone tube, while warm water served as extraction solvent and was delivered at a flow rate of 2.5 mL/min to generate considerable back pressure at either vessel. A column oven heated both the solvent and crude materials. A TFC column, which is advantageous for the comprehensive trapping of small molecular substances from fluids under turbulent flow conditions, was employed to transfer analytes from the PWWE module to LC-MS/MS. Two electronic valves alternated each vessel between extraction and elution phases. As a proof-of-concept, a famous herbal medicine for the treatment of neurodegenerative disorders, namely Polygalae Radix, was selected for the qualitative and quantitative analyses. The results suggest that the hybrid platform is advantageous in terms of decreasing time, material, and solvent consumption and in its automation, versatility, and environmental friendliness.Entities:
Year: 2016 PMID: 27272557 PMCID: PMC4895155 DOI: 10.1038/srep27303
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Schematic diagram of the online PWWE module.
Detailed descriptions are included in the section “Configuration of PWWE module and assessment of the extraction efficiency.”
Figure 2Schematic diagram of the online PWWE-TFC-LC-MS/MS platform.
(A) extraction phase for Vessel 1, and both valves were maintained at A-channel (1-A and 2-A); (B) elution phase for Vessel 1, and Valves 1 and 2 were maintained at A-channel and B-channel (1-A and 2-B), respectively; (C) extraction phase for Vessel 2, and Valves 1 and 2 were maintained at B-channel and A-channel (1-B and 2-A), respectively; (D) elution phase for Vessel 1, and both valves were maintained at B-channel (1-B and 2-B). Detailed descriptions are included in the section “Configuration of the online PWWE-TFC-LC-MS/MS system”.
Figure 3Representative overlaid extracted ion current (EIC) chromatograms of a mixed standard solution (A) and selected crude materials (PR4, B) by PWWE-TFC-LC-MS/MS. 6-HT, 6-hydroxy-1,2,3,7-tetramethoxyxanthone; LAN, lancerin; MAN, mangiferin; 7-MM, 7-O-methoxyl-mangiferin; SA5, sibiricose A5; SA6, sibiricose A6; P-IX, polygalaxanthone IX; P-IV, polygalaxanthone IV; P-VIII, polygalaxanthone VIII; P-VII, polygalaxanthone VII; TEB, tenuifoliside (B) TEN, tenuifolin; TEA, tenuifoliside A; 3,6′-DS, 3,6′-disinapoyl sucrose.
Linear regression data, lower limits of quantification (LLOQs), and limits of detection (LODs) for all targeted analytes.
| Compound | Calibration curves | Range (ng/mL) | LOD (ng/mL) | LOQ (ng/mL) | |
|---|---|---|---|---|---|
| 6-Hydroxy-1,2,3,7-tetramethoxyxanthone | y = 0.816x − 0.0197 | 0.9986 | 16–4000 | 1.28 | 3.2 |
| Lancerin | y = 0.831x + 0.222 | 0.9986 | 80–4000 | 0.96 | 2.24 |
| Mangiferin | y = 0.596x + 0.301 | 0.9988 | 80–4000 | 1.28 | 3.2 |
| 7- | y = 0.213x + 0.0631 | 0.9978 | 80–4000 | 3.2 | 6.4 |
| Sibiricose A5 | y = 0.018x − 0.00874 | 0.9988 | 160–20000 | 6.4 | 16 |
| Sibiricose A6 | y = 0.153x − 0.00507 | 0.9976 | 32–4000 | 0.64 | 1.28 |
| Polygalaxanthone IX | y = 0.42x + 0.206 | 0.9982 | 80–4000 | 0.64 | 1.28 |
| Polygalaxanthone IV | y = 0.902x + 0.511 | 0.9980 | 80–4000 | 0.26 | 0.64 |
| Polygalaxanthone VIII | y = 0.0331 − 0.00696 | 0.9994 | 160–100000 | 4.8 | 6.4 |
| Polygalaxanthone VII | y = 0.138x + 0.0226 | 0.9998 | 80–4000 | 1.28 | 2.24 |
| Tenuifoliside B | y = 0.0994x + 0.0101 | 0.9968 | 80–10000 | 1.28 | 3.2 |
| Tenuifolin | y = 0.294 − 0.000497 | 0.9980 | 6.4–4000 | 0.96 | 3.2 |
| Tenuifoliside A | y = 0.048x + 0.0222 | 0.9984 | 80–4000 | 6.4 | 32 |
| 3,6′-Disinapoyl sucrose | y = 0.166x − 0.135 | 0.9998 | 160–100000 | 1.28 | 3.2 |
Intra- and inter-day assay results (RSD%) of quality control samples (high, medium, and low concentration levels), and recovery assay (high, medium, and low concentration levels) results for all targeted analytes.
| Analyte | Intra-day RSD (%, | Inter-day RSD (%, | Recovery (%, | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Low (160 ng/mL) | Medium (800 ng/mL) | High (3000 ng/mL) | Low (160 ng/mL) | Medium (800 ng/mL) | High (3000 ng/mL) | Low | Medium | High | ||||
| Mean | RSD | Mean | RSD | Mean | RSD | |||||||
| 6-Hydroxy-1,2,3,7-tetramethoxyxanthone | 4.12 | 4.50 | 2.36 | 5.01 | 6.46 | 1.89 | 85.82 | 5.67 | 97.83 | 10.39 | 114.6 | 11.45 |
| Lancerin | 4.00 | 2.96 | 4.10 | 5.12 | 1.64 | 2.65 | 86.85 | 11.43 | 89.92 | 9.95 | 95.05 | 12.93 |
| Mangiferin | 3.12 | 3.54 | 4.51 | 2.59 | 1.83 | 3.86 | 91.61 | 3.52 | 90.20 | 12.37 | 95.46 | 13.30 |
| 7- | 4.90 | 3.55 | 2..86 | 4.02 | 3.11 | 3.60 | 106.1 | 30.77 | 109.5 | 13.46 | 88.60 | 9.38 |
| Sibiricose A5 | 7.88 | 4.41 | 2.98 | 4.49 | 4.10 | 3.12 | N.Q. | N.A. | N.Q. | N.A. | N.Q. | N.A. |
| Sibiricose A6 | 3.58 | 3.40 | 3.88 | 3.80 | 4.37 | 5.27 | N.Q. | N.A. | N.Q. | N.A. | N.Q. | N.A. |
| Polygalaxanthone IX | 3.03 | 1.98 | 4.67 | 4.61 | 3.17 | 4.56 | 91.14 | 7.10 | 95.20 | 14.73 | 92.91 | 11.16 |
| Polygalaxanthone IV | 3.84 | 2.57 | 2.71 | 3.59 | 3.20 | 5.56 | 95.17 | 11.63 | 98.08 | 10.09 | 101.3 | 5.55 |
| Polygalaxanthone VIII | 4.88 | 2.83 | 4.96 | 4.59 | 3.57 | 4.68 | 89.30 | 14.12 | 107.1 | 1.60 | 103.51 | 5.36 |
| Polygalaxanthone VII | 3.16 | 2.25 | 1.68 | 3.72 | 1.30 | 5.70 | N.Q. | N.A. | N.Q. | N.A. | N.Q. | N.A. |
| Tenuifoliside B | 3.34 | 2.13 | 5.49 | 4.93 | 4.14 | 8.32 | N.Q. | N.A. | N.Q. | N.A. | N.Q. | N.A. |
| Tenuifolin | 8.36 | 4.80 | 4.53 | 5.21 | 3.89 | 5.32 | 99.77 | 9.43 | 108.57 | 11.62 | 106.0 | 1.06 |
| Tenuifoliside A | 7.05 | 4.96 | 3.54 | 5.29 | 7.10 | 5.36 | N.Q. | N.A. | N.Q. | N.A. | N.Q. | N.A. |
| 3,6′-Disinapoyl sucrose | 3.90 | 5.00 | 3.48 | 3.47 | 5.68 | 5.35 | N.Q. | N.A. | N.Q. | N.A. | N.Q. | N.A. |
aN.Q., not quantifiable due to beyond upper limit of quantitation.
bN.A., not applicable.
The contents of fourteen investigated compounds in ten batches of Polygalae Radix (PR1–PR10).
| No. | Habitat | Content (μg/g) | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6-HT | LAN | MAN | 7-MM | SA5 | SA6 | P-IX | P-IV | P-VIII | P-VII | TEB | TEN | TEA | 3,6′-DS | ||
| PR-1 | Shanxi | 4.15 | 11.73 | 1.49 | 39.91 | N.Q. | N.Q. | 22.00 | 5.69 | 406.22 | N.Q. | N.Q. | 11.82 | N.Q. | 866.67 |
| PR-2 | Shaanxi | 12.19 | 13.00 | 3.87 | 1.04 | N.Q. | N.Q. | 31.76 | 7.67 | 474.29 | N.Q. | N.Q. | 11.62 | N.Q. | 961.90 |
| PR-3 | Hebei | 14.49 | 14.98 | 1.36 | 51.43 | N.Q. | N.Q. | 25.47 | 7.31 | 551.02 | N.Q. | N.Q. | 9.67 | N.Q. | 885.71 |
| PR-4 | He’nan | 13.71 | 16.25 | 2.82 | 61.25 | N.Q. | N.Q. | 30.38 | 8.08 | 545.83 | N.Q. | N.Q. | 9.96 | N.Q. | 833.33 |
| PR-5 | Sichuan | 2.80 | 13.90 | 2.51 | 52.20 | N.Q. | N.Q. | 25.37 | 8.73 | 595.12 | N.Q. | N.Q. | 13.12 | N.Q. | 1112.20 |
| PR-6 | Anhui | 12.51 | 23.79 | 4.89 | 101.70 | N.Q. | N.Q. | 68.09 | 13.15 | 948.94 | N.Q. | N.Q. | 27.83 | N.Q. | 855.32 |
| PR-7 | Inner Mongolia | 10.87 | 14.87 | 2.83 | 58.70 | N.Q. | N.Q. | 39.48 | 9.70 | 513.04 | N.Q. | N.Q. | 10.61 | N.Q. | 726.09 |
| PR-8 | Liaoning | 20.18 | 25.33 | 5.87 | 118.67 | N.Q. | N.Q. | 64.44 | 11.33 | 991.11 | N.Q. | N.Q. | 23.42 | N.Q. | 893.33 |
| PR-9 | Heibei | 5.40 | 18.65 | 5.67 | 93.95 | N.Q. | N.Q. | 58.14 | 15.95 | 888.37 | N.Q. | N.Q. | 25.95 | N.Q. | 352.09 |
| PR-10 | Shanxi | 3.84 | 18.31 | 3.02 | 94.22 | N.Q. | N.Q. | 31.78 | 5.91 | 755.56 | N.Q. | N.Q. | 13.87 | N.Q. | 853.33 |
a6-HT, 6-hydroxy-1,2,3,7-tetramethoxyxanthone; LAN, lancerin; MAN, mangiferin; 7-MM, 7-O-methoxy-mangiferin; SA5, sibiricose A5; SA6, sibiricose A6; P-IX, polygalaxanthone IX; P-IV, polygalaxanthone IV; P-VIII, polygalaxanthone VIII; P-VII, polygalaxanthone VII; TEB, tenuifoliside B; TEN, tenuifolin; TEA, tenuifoliside A; 3,6′-DS, 3,6′-disinapoyl sucrose.
bN.Q., not quantifiable due to greater than the upper limit of quantitation.